EMA — authorised 27 July 2006
- Application: EMEA/H/C/000657
- Marketing authorisation holder: Les Laboratoires Servier
- Local brand name: Thymanax
- Status: rejected
🇪🇺 Thymanax in European Union
EMA authorised Thymanax on 27 July 2006
Marketing authorisations
EMA — authorised 19 February 2009
- Marketing authorisation holder: Les Laboratoires Servier
- Status: approved
EMA — authorised 19 February 2009
- Application: EMEA/H/C/000916
- Marketing authorisation holder: Servier (Ireland) Industries Ltd
- Local brand name: Thymanax
- Indication: Treatment of major depressive episodes in adults.
- Status: withdrawn
Thymanax in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Thymanax approved in European Union?
Yes. EMA authorised it on 27 July 2006; EMA authorised it on 19 February 2009; EMA authorised it on 19 February 2009.
Who is the marketing authorisation holder for Thymanax in European Union?
Les Laboratoires Servier holds the EU marketing authorisation.